Search Results - "Stumpp, T."

Refine Results
  1. 1

    Half-life extension using serum albumin-binding DARPin® domains by Steiner, Daniel, Merz, Frieder W, Sonderegger, Ivo, Gulotti-Georgieva, Maya, Villemagne, Denis, Phillips, Douglas J, Forrer, Patrik, Stumpp, Michael T, Zitt, Christof, Binz, H Kaspar

    Published in Protein engineering, design and selection (01-09-2017)
    “…Abstract A long systemic half-life is key for therapeutic proteins. To that end we have generated serum albumin-binding designed ankyrin repeat domains. These…”
    Get full text
    Journal Article
  2. 2

    High-affinity binders selected from designed ankyrin repeat protein libraries by Kohl, Andreas, Forrer, Patrik, Briand, Christophe, Stumpp, Michael T, Binz, H Kaspar, Amstutz, Patrick, Grütter, Markus G, Plückthun, Andreas

    Published in Nature biotechnology (01-05-2004)
    “…We report here the evolution of ankyrin repeat (AR) proteins in vitro for specific, high-affinity target binding. Using a consensus design strategy, we…”
    Get full text
    Journal Article
  3. 3

    DARPins: A new generation of protein therapeutics by Stumpp, Michael T., Binz, H. Kaspar, Amstutz, Patrick

    Published in Drug discovery today (01-08-2008)
    “…DARPins (designed ankyrin repeat proteins) are a novel class of binding molecules with the potential to overcome limitations of monoclonal antibodies, hence…”
    Get full text
    Journal Article
  4. 4

    Comprehensive Survey of Proteins Targeted by Chloroplast Thioredoxin by Motohashi, Ken, Kondoh, Aiko, Stumpp, Michael T., Hisabori, Toru

    “…Possible target proteins of chloroplast thioredoxin (Trx) have been investigated in the stroma lysate of spinach chloroplasts. For that purpose, we immobilized…”
    Get full text
    Journal Article
  5. 5

    Designing Repeat Proteins: Well-expressed, Soluble and Stable Proteins from Combinatorial Libraries of Consensus Ankyrin Repeat Proteins by Binz, H.Kaspar, Stumpp, Michael T, Forrer, Patrik, Amstutz, Patrick, Plückthun, Andreas

    Published in Journal of molecular biology (12-09-2003)
    “…We describe an efficient way to generate combinatorial libraries of stable, soluble and well-expressed ankyrin repeat (AR) proteins. Using a combination of…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Designed to Be Stable: Crystal Structure of a Consensus Ankyrin Repeat Protein by Kohl, Andreas, Binz, H. Kaspar, Forrer, Patrik, Stumpp, Michael T., Plückthun, Andreas, Grütter, Markus G.

    “…Ankyrin repeat (AR) proteins mediate innumerable protein-protein interactions in virtually all phyla. This finding suggested the use of AR proteins as designed…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Designing Repeat Proteins: Modular Leucine-rich Repeat Protein Libraries Based on the Mammalian Ribonuclease Inhibitor Family by Stumpp, Michael T., Forrer, Patrik, Binz, H.Kaspar, Plückthun, Andreas

    Published in Journal of molecular biology (12-09-2003)
    “…We present a novel approach to design repeat proteins of the leucine-rich repeat (LRR) family for the generation of libraries of intracellular binding…”
    Get full text
    Journal Article
  11. 11

    Intracellular Kinase Inhibitors Selected from Combinatorial Libraries of Designed Ankyrin Repeat Proteins by Amstutz, Patrick, Binz, H. Kaspar, Parizek, Petra, Stumpp, Michael T., Kohl, Andreas, Grütter, Markus G., Forrer, Patrik, Plückthun, Andreas

    Published in The Journal of biological chemistry (01-07-2005)
    “…The specific intracellular inhibition of protein activity at the protein level allows the determination of protein function in the cellular context. We…”
    Get full text
    Journal Article
  12. 12

    Consensus Design of Repeat Proteins by Forrer, Patrik, Binz, H. Kaspar, Stumpp, Michael T, Plückthun, Andreas

    “…Consensus design is a valuable protein-engineering method that is based on statistical information derived from sequence alignments of homologous proteins…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Carnitine partially protects the rat testis against the late damage produced by doxorubicin administered during pre‐puberty by Cabral, R. E. L., Okada, F. K., Stumpp, T., Vendramini, V., Miraglia, S. M.

    Published in Andrology (Oxford) (01-11-2014)
    “…Summary Doxorubicin, an anticancer drug, is widely included in chemotherapy protocols to combat childhood cancer. Carnitine, an important quaternary amine, is…”
    Get full text
    Journal Article
  15. 15

    Beyond Antibodies: The DARPin® Drug Platform by Stumpp, Michael T., Dawson, Keith M., Binz, H. Kaspar

    “…The DARPin ® drug platform was established with a vision to expand the medical use of biologics beyond what was possible with monoclonal antibodies. It is…”
    Get full text
    Journal Article
  16. 16

    Effects of prenatal and lactation nicotine exposure on rat testicular interstitial tissue by Paccola, C. C., Neves, F. M. O., Cipriano, I., Stumpp, T., Miraglia, S. M.

    Published in Andrology (Oxford) (01-03-2014)
    “…Summary Nicotine is largely consumed as a component of cigarettes. It induces apoptosis, interferes with endocrine function by changing the sex hormones…”
    Get full text
    Journal Article
  17. 17

    A novel strategy to design binding molecules harnessing the modular nature of repeat proteins by Forrer, Patrik, Stumpp, Michael T., Binz, H.Kaspar, Plückthun, Andreas

    Published in FEBS letters (27-03-2003)
    “…Repeat proteins, such as ankyrin or leucine-rich repeat proteins, are ubiquitous binding molecules, which occur, unlike antibodies, intra- and extracellularly…”
    Get full text
    Journal Article
  18. 18
  19. 19

    The trispecific DARPin ensovibep inhibits diverse SARS-CoV-2 variants by Rothenberger, Sylvia, Hurdiss, Daniel L., Walser, Marcel, Malvezzi, Francesca, Mayor, Jennifer, Ryter, Sarah, Moreno, Hector, Liechti, Nicole, Bosshart, Andreas, Iss, Chloé, Calabro, Valérie, Cornelius, Andreas, Hospodarsch, Tanja, Neculcea, Alexandra, Looser, Thamar, Schlegel, Anja, Fontaine, Simon, Villemagne, Denis, Paladino, Maria, Schiegg, Dieter, Mangold, Susanne, Reichen, Christian, Radom, Filip, Kaufmann, Yvonne, Schaible, Doris, Schlegel, Iris, Zitt, Christof, Sigrist, Gabriel, Straumann, Marcel, Wolter, Julia, Comby, Marco, Sacarcelik, Feyza, Drulyte, Ieva, Lyoo, Heyrhyoung, Wang, Chunyan, Li, Wentao, Du, Wenjuan, Binz, H. Kaspar, Herrup, Rachel, Lusvarghi, Sabrina, Neerukonda, Sabari Nath, Vassell, Russell, Wang, Wei, Adler, Julia M., Eschke, Kathrin, Nascimento, Mariana, Abdelgawad, Azza, Gruber, Achim D., Bushe, Judith, Kershaw, Olivia, Knutson, Charles G., Balavenkatraman, Kamal K., Ramanathan, Krishnan, Wyler, Emanuel, Teixeira Alves, Luiz Gustavo, Lewis, Seth, Watson, Randall, Haeuptle, Micha A., Zürcher, Alexander, Dawson, Keith M., Steiner, Daniel, Weiss, Carol D., Amstutz, Patrick, van Kuppeveld, Frank J. M., Stumpp, Michael T., Bosch, Berend-Jan, Engler, Olivier, Trimpert, Jakob

    Published in Nature biotechnology (01-12-2022)
    “…The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants with potential resistance to existing drugs emphasizes the need for new…”
    Get full text
    Journal Article
  20. 20